Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 4,849-4,860 of 10,592

Drug study icon

CompletedNCT00218439

Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Minnesota
Condition: Addiction

Drug study icon

CompletedNCT03720847

Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of North Carolina, Chapel Hill
Condition: Suicidality

Drug study icon

CompletedNCT05494437

Effect of PP-01 on Cannabis Withdrawal Syndrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: PleoPharma, Inc.
Condition: Addiction

Drug study icon

WithdrawnNCT00890643

Effect of Prazosin on Neurophysiology and Cognition in PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: PTSD

Drug study icon

CompletedNCT00271206

Effect of Progesterone on Smoking Behavior in Male and Female Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

CompletedNCT00158262

Effect of Propranolol on Preventing PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: PTSD

Drug study icon

CompletedNCT02560324

Effect of Ramelteon on Smoking Abstinence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Behavioral study icon

CompletedNCT00554320

Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Summa Health System
Condition: PTSD

Device study icon

CompletedNCT01620086

Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDeviceFrom 21 Years to 65 Years

Countries: United States
Sponsor: University of Arkansas
Condition: Schizophrenia

Device study icon

CompletedNCT03993509

Effect of rTMS on Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDeviceFrom 18 Years to 50 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Anxiety

Drug study icon

CompletedNCT05470465

Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Food and Drug Administration (FDA)
Condition: Depression

Drug study icon

CompletedNCT00646581

Effect of Single Dose Intranasal Insulin On Cognitive Function

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Massachusetts, Worcester
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.